The STELVIO trial, a game changer for bronchoscopic lung volume reduction in patients with severe emphysema

The STELVIO trial was crucial to ensure that bronchoscopic lung volume reduction using one-way valves has evolved from an experimental intervention into a state-of-the-art treatment option for specific patients with advanced emphysema http://bit.ly/2IgMrsp

Detalles Bibliográficos
Autores principales: Posthuma, Rein, Vanfleteren, Lowie E.G.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078737/
https://www.ncbi.nlm.nih.gov/pubmed/32194773
http://dx.doi.org/10.1183/20734735.0004-2020
Descripción
Sumario:The STELVIO trial was crucial to ensure that bronchoscopic lung volume reduction using one-way valves has evolved from an experimental intervention into a state-of-the-art treatment option for specific patients with advanced emphysema http://bit.ly/2IgMrsp

Ejemplares similares